Detailed kinetic studies of an aggregating inhibitor; inhibition of phosphomannomutase/phosphoglucomutase by disperse blue 56.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Biochemistry

• Publication date

  2004-07-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI0491907PMID 15236574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The behavior and significance of slow-binding enzyme inhibitors.

  2006cited by this paper
• Structural basis of diverse substrate recognition by the enzyme PMM/PGM from P. aeruginosa.

  2004cited by this paper
• Roles of active site residues in Pseudomonas aeruginosa phosphomannomutase/phosphoglucomutase.

  2003cited by this paper
• A specific mechanism of nonspecific inhibition.

  2003cited by this paper
• A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

  2002cited by this paper
• Kinetic mechanism and pH dependence of the kinetic parameters of Pseudomonas aeruginosa phosphomannomutase/phosphoglucomutase.

  2001cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Lung infections. 3. Pseudomonas aeruginosa and other related species.

  1998cited by this paper
• Program DYNAFIT for the analysis of enzyme kinetic data: application to HIV proteinase.

  1996cited by this paper
• Purification and characterization of phosphomannomutase/phosphoglucomutase from Pseudomonas aeruginosa involved in biosynthesis of both alginate and lipopolysaccharide

  1994cited by this paper
• Transition state analysis and inhibitor design for enzymatic reactions.

  1994cited by this paper
• Inhibition of phosphoglucomutase by vanadate.

  1990cited by this paper
• Characterization of vanadate-based transition-state-analogue complexes of phosphoglucomutase by spectral and NMR techniques.

  1990cited by this paper

• Identification, Characteristics and Function of Phosphoglucomutase (PGM) in the Agar Biosynthesis and Carbon Flux in the Agarophyte Gracilariopsis lemaneiformis (Rhodophyta)

  2022cites this paper
• Genetic and structural validation of phosphomannomutase as a cell wall target in Aspergillus fumigatus

  2021cites this paper
• Extending the investigation of 4-thiazolidinone derivatives as potential multi-target ligands of enzymes involved in diabetes mellitus and its long-term complications: A study with pancreatic α-amylase.

  2020cites this paper
• Controlling the Stability of Colloidal Drug Aggregates for Chemotherapeutic Delivery

  2019cites this paper
• Inhibitory evaluation of αPMM/PGM from Pseudomonas aeruginosa: chemical synthesis, enzyme kinetic and protein crystallographic study.

  2019cites this paper
• Colloidal aggregation: from screening nuisance to formulation nuance.

  2018cites this paper
• Mechanism of Selective Enzyme Inhibition through Uncompetitive Regulation of an Allosteric Agonist.

  2018cites this paper
• Internal Structure and Preferential Protein Binding of Colloidal Aggregates.

  2017cites this paper
• Complements to Enzyme–Modifier Interactions

  2015cites this paper
• Kinetics of Enzyme-Modifier Interactions

  2015cites this paper
• Genetic and structural validation of Aspergillus fumigatus N-acetylphosphoglucosamine mutase as an antifungal target

  2013cites this paper
• Non-stoichiometric inhibition in biochemical high-throughput screening

  2011cites this paper
• Complementarity Between a Docking and a High-Throughput Screen in Discovering New Cruzain Inhibitors

  2010cites this paper
• Colloid Formation by Drugs in Simulated Intestinal Fluid

  2010cites this paper
• False positives in the early stages of drug discovery.

  2010cites this paper
• Promiscuous Aggregate-Based Inhibitors Promote Enzyme Unfolding

  2009cites this paper
• Divergent modes of enzyme inhibition in a homologous structure-activity series.

  2009cites this paper
• Stoichiometry and physical chemistry of promiscuous aggregate-based inhibitors.

  2008cites this paper
• Promiscuous Ligands

  2007cites this paper
• A high-throughput screen for aggregation-based inhibition in a large compound library.

  2007cites this paper
• Stability and equilibria of promiscuous aggregates in high protein milieus.

  2007cites this paper
• Screening in a spirit haunted world.

  2006cites this paper
• Sensitivity analysis and error structure of progress curves.

  2006cites this paper
• Cyanine dye N744 inhibits tau fibrillization by blocking filament extension: implications for the treatment of tauopathic neurodegenerative diseases.

  2005cites this paper